Home › Research › Tau biomarkers
Blood-based biomarkers for early diagnosis of Alzheimer's disease: a current systematic review of diagnostic accuracy studies
Efe JJ, Anibor E, Pandey P, Sunday OG, Innocent DC, Anyakorah PE, Emmanuel OI.. BMC neurology, 2026-06-05
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Alzheimer disease (AD) is the most common cause of dementia in the world and its prevalence is increasing and it has important public health consequences. Early diagnosis remains challenging due to reliance on costly and invasive methods such as positron emission tomography (PET) and cerebrospinal fluid (CSF) analysis. Blood-based biomarkers have emerged as a promising, less invasive alternatives to identify AD pathology, especially in the early and preclinical stages.
What this study adds
Evidence grade: High
This is a pooled review. This systematic review looked at how accurately blood-based biomarkers can detect Alzheimer disease early, compared with costly and invasive PET and CSF methods. Reported effect size: AUC 0.69-0.94.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Efe, J. J., Anibor, E., Pandey, P., Sunday, O. G., Innocent, D. C., Anyakorah, P. E., et al. (2026). Blood-based biomarkers for early diagnosis of Alzheimer's disease: a current systematic review of diagnostic accuracy studies. BMC neurology. https://doi.org/10.1186/s12883-026-05046-6
Vancouver
Efe JJ, Anibor E, Pandey P, Sunday OG, Innocent DC, Anyakorah PE, et al. Blood-based biomarkers for early diagnosis of Alzheimer's disease: a current systematic review of diagnostic accuracy studies. BMC neurology. 2026. doi:10.1186/s12883-026-05046-6. PMID: 42243744.
BibTeX
@article{efe2026-42243744,
author = {Efe, J. J. and Anibor, E. and Pandey, P. and Sunday, O. G. and Innocent, D. C. and Anyakorah, P. E. and Emmanuel, O. I.},
title = {{Blood-based biomarkers for early diagnosis of Alzheimer's disease: a current systematic review of diagnostic accuracy studies}},
journal = {BMC neurology},
year = {2026},
doi = {10.1186/s12883-026-05046-6},
pmid = {42243744},
url = {https://doi.org/10.1186/s12883-026-05046-6}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Early diagnosis remains challenging due to reliance on costly and invasive methods such as positron emission tomography (PET) and cerebrospinal fluid (CSF) analysis.
- Blood-based biomarkers have emerged as a promising, less invasive alternatives to identify AD pathology, especially in the early and preclinical stages.
- This systematic review aim to evaluate the diagnostic accuracy of blood-based biomarkers for the early detection of Alzheimer's disease.
- Methods An extensive literature search was performed in PubMed/MEDLINE, EMBASE, Scopus, Web of Science, and Cochrane Library on studies published since 2010 up to March 2026.
Why it matters
This systematic review looked at how accurately blood-based biomarkers can detect Alzheimer disease early, compared with costly and invasive PET and CSF methods. It is about improving diagnosis, not about treating, curing or preventing the disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designsystematic review
- Effect sizeAUC 0.69-0.94
- Evidence strengthHigh
How this study scored 51/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size and studied in people because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 49 of the 96 points we could judge it on, which is 51 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (BMC neurology) |
| Journal's citation record | 1 / 4 | BMC Neurology: journal h-index 122 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Okolie Ikechukwu Emmanuel holds only 3 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | University of Lancashire: institution h-index 307 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42243744) |
| Free to read | 2 / 2 | Free to read |
| Points | 49 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 49 of the 96 points we could judge it on is 51 out of 100. |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.